Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
95 hedge funds and large institutions have $168M invested in Aratana Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 18 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 27
13% more call options, than puts
Call options by funds: $18K | Put options by funds: $16K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 98 → 95 (-3)
6% less capital invested
Capital invested by funds: $178M → $168M (-$9.87M)
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$3.9M |
| 2 |
AIC
AWM Investment Company
New York
|
+$2.83M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.12M |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$1.92M |
| 5 |
PA
Perceptive Advisors
New York
|
+$1.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.14M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$4.35M |
| 3 |
O
OppenheimerFunds
New York
|
-$3.24M |
| 4 |
Millennium Management
New York
|
-$2.37M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$1.62M |
PETX Hedge Fund Activity: Q1 2016 in Review
95 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q1 2016, worth a combined $168M — down 5.5% from $178M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of PETX and 16 opened new positions — a net loss of 2 holders — while 27 trimmed existing stakes and 32 added.
The largest buyer was Franklin Resources, adding an estimated $3.9M. The largest seller was Wellington Management Group, cutting an estimated $5.14M.
- 95 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q1 2016, down from 98 in Q4 2015.
- Funds reported $168M of Aratana Therapeutics, Inc. stock for Q1 2016, down 5.5% quarter-over-quarter.
- 16 funds opened new Aratana Therapeutics, Inc. positions in Q1 2016 and 18 closed out, a net change of -2 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q1 2016 was Franklin Resources, an estimated $3.9M added.
- The largest Aratana Therapeutics, Inc. seller in Q1 2016 was Wellington Management Group, an estimated $5.14M sold.
Based on aggregated 13F filings for Q1 2016.